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Haptoglobin 2-1 phenotype predicts rapid growth
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Jaroslaw Piatek, PhD,c and Piotr Gutowski, MD, PhD,a Szczecin, Poland
Background: Haptoglobin (Hp) polymorphism is associated with the prevalence and clinical evolution of many inflam-
matory diseases and atherosclerosis. Circulating neutrophils and neutrophil-associated proteases are an important initial
component of experimental abdominal aortic aneurysm (AAA) formation. Elastase and C-reactive protein (CRP) levels
are elevated in patients with AAAs. This study assessed the relationship between AAA expansion and Hp phenotypes,
neutrophil count, elastase, and CRP levels.
Methods: Eighty-three consecutive AAA patients underwent annual ultrasound scans. Three major Hp phenotypes (1-1,
2-1, and 2-2) were determined, and the neutrophil count, serum elastase, and high-sensitivity (hs) CRP levels were
measured at the initial examination. After initial screening, patients were rescanned at 6- to 12-month intervals up to a
period of 2 to 7 years. The mean yearly growth of the AAA largest transverse diameter was estimated for each group of
Hp patients. The results are presented as median (interquartile range).
Results:Hp 2-1 patients had a significantly higher growth rate (3.69 [2.40] mm/y) of AAA compared with patients with
Hp 2-2 (1.24 [0.79], P < .00001) and Hp 1-1 (1.45 [0.68], P  .00004). This association remained significant in the
multivariate analysis. Elevated elastase serum activity was also evident in AAA patients with Hp 2-1 (0.119 [0.084]
arbitrary units) in contrast toHp 2-2 (0.064 [0.041], P< .00001) andHp 1-1 (0.071 [0.040], P .0006) patients. CRP
serum levels (mg/L) were significantly higher in patients with Hp 2-1 (7.2 [7.1]) than in Hp 2-2 (3.4 [3.1], P .0058)
and Hp 1-1 (2.8 [4.1], P  .044). The neutrophil count was not significantly different among Hp groups.
Conclusions: The Hp 2-1 phenotype showed a strong association with increased rates of the expansion of AAAs and may
be a useful independent predictor of growth rate. Further large follow-up studies will be needed to investigate the
pathomechanisms of association and the role of elastase and inflammation in the progression of AAA. (J Vasc Surg 2010;
52:691-6.)
Clinical Relevance:Elective surgical or endovascular repair is recommended for large aneurysms, whereas small aneurysms
are managed by watchful waiting. The diameter and rate of growth of the AAA are the most important determinants of
the risk of rupture and in deciding when elective repair is justified. In the present study, the Hp 2-1 phenotype predicted
rapid aneurysm expansion. This may have implications for the frequency of follow-up and timing of repair of AAA in
patients with the Hp 2-1 phenotype.Although abdominal aortic aneurysm (AAA) is an im-
portant cardiovascular disease, the genetic and environ-
mental risk factors that contribute to an increase in the
likelihood that an aneurysm will develop in an individual
are nonetheless still poorly understood. Ongoing research
into the genetic components of AAA using a candidate
gene approach has been generally unsuccessful. However,
significant evidence has emerged in recent years to suggest
that chronic aortic wall inflammation causes connective
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doi:10.1016/j.jvs.2010.03.016tissue remodeling. Observational studies have highlighted a
familial trend toward AAA development among the rela-
tives of individuals with AAA, and it is thought that such
inflammatory genes may influence an individual’s suscepti-
bility. Genetic influences may also be crucial in the regula-
tion of inflammatory responses.1 Heredity and inflamma-
tion appear to be important factors in the development
of AAA.2
Haptoglobin (Hp) is a hemoglobin-binding protein
expressed by a genetic polymorphism as three major phe-
notypes: Hp 1-1, Hp 2-1, and Hp 2-2, that are the prod-
ucts of two alleles (Hp 1 and Hp 2). The Hp 1-1 protein is
biologically the most effective in binding free hemoglobin
and suppressing inflammatory responses, Hp 2-2 is the least
active, and Hp 2-1 is moderately active.3 Most attention
has been paid to determining the Hp phenotype as a
genetic fingerprint used in forensic medicine. Several func-
tional differences between Hp phenotypes have also been
shown to have important biologic and clinical consequences.4
Hp 2-2 is reported to be associated with the risk of athero-
sclerosis and coronary heart disease, including myocardial
infarction.5 The frequency of the Hp 1 allele was signifi-
cantly increased in patients with aneurysms compared with
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2-1 and Hp 1-1 possess a far higher activity to stimulate
elastin hydrolysis by leucocyte elastase than that of Hp
2-2.6 In fact, Hp 2-2 has no effect on elastin hydrolysis by
neutrophil elastase, indicating that Hp 2-1 and Hp 1-1
specifically affect elastin by making it more susceptible to
degradation. Corresponding to these data, Hp 2-2 patients
had the highest mean age at aneurysm resection.6 Variation
in the Hp gene appears to influence the dilatation of the
abdominal aorta and probably has a direct effect on the
degradation of elastin in the atherosclerotic aorta.6
This study tested the hypothesis that theHp phenotype
affects the growth rate of aneurysm, serum elastase activity,
and markers of inflammation in patients with newly diag-
nosed AAA.
METHODS
The Bioethical Committee of the Pomeranian Medical
University, Szczecin, Poland, approved the study protocol.
The nature of the study was explained to the patients, and
their written consent was obtained.
Patients. The study enrolled 83 consecutive patients
(73 men, 10 women) with a recent diagnosis of AAA
referred to the outpatient clinic of the Department of
Vascular Surgery and Angiology of Pomeranian Medical
University between February 2000 and January 2006. Pa-
tients were 66.9 7.7 years old and had a body mass index
of 25.8 4.1 kg/m2. The study excluded individuals with
symptomatic or ruptured AAA.
Shortly after enrollment, the initial examination was ar-
ranged and ultrasound imagingwas performed to confirm the
AAA diagnosis and measure the initial aneurysm diameter. A
blood sample was also taken, and patients were queried about
comorbidities, which were confirmed bymedical documenta-
tion, smoking, and pharmacologic treatment, including
-blockers, statins, and antiplatelet drugs.
An AAAwas defined as a focal dilation of the abdominal
aorta with a diameter 30 mm, which is a standard crite-
rion for many clinical trials. The patients were prospectively
observed and underwent repeat ultrasound scans (maximal
anteroposterior diameter) at 6- to 12-month intervals to
monitor the growth of the aneurysm during a period of 2 to
7 years, or until AAA operation, loss of contact, or the end
of the study. Operative intervention was considered for
patients with AAA55 mm. The follow-up was continued
in the AAA patients with large aneurysms (55 mm) when
they did not consent to have surgery at the time.
The same experienced radiologist examined all of the
patients. The maximal anteroposterior diameter of the aorta
was measured using VOLUSON 730Pro with CONVEX
probe (General Electric Medical Systems, Wien, Austria) in
color Doppler mode.
The average rate of growth was calculated as the change
in aortic diameter over time, using the formula:
Growth rate (mm ⁄ y) max diameter at last scan
max diameter at first scan ⁄ time interval.Laboratory analysis. The methods for Hp phenotyp-
ing, estimation of serum elastase activity, and neutrophil
count in the peripheral blood have been previously de-
scribed in detail.7 The blood was sampled from the periph-
eral vein of fasting patients. One tube (without anticoagu-
lant) was centrifuged1 hour, and the serum samples were
stored at –20°C. The second tube (containing ethylenedia-
minetetraacetic acid) was used for neutrophil count. Hp
phenotyping was performed by starch-gel electrophoresis.
The serum, which contains free hemoglobin added in ex-
cess, provides a haptoglobin-hemoglobin complex of one
of three phenotypes, which is observed after benzidine
staining.7
Serum elastase activity was measured using a kit (Enzy-
matic Assay of ELASTASE, Leukocyte, E-8140, Sigma-
Aldrich, Poznan, Poland) according to the manufacturer’s
instructions with an ultraviolet-visible spectrophotometry
Lambda 40 P spectrophotometer (Perkin Elmer, Turku,
Finland) and expressed in arbitrary units based on change
of absorbance at 347.5 nm.
High-sensitivity CRP (hsCRP) serum concentration
was measured using the sandwich enzyme immunoassay
test CRP (EUROIMMUNN-ELISA,Medizinische Labor-
diagnostika AG, Lübeck, Germany) with EnVision 2104
Multilabel Reader (Perkin Elmer). The detection limit for
hsCRP was 0.8 ng/mL and intra-assay precision (CV%)
was 5.0% to 5.8 %. The neutrophil count was determined by
the automated hematology analyser CELLDYN 3700 (Ab-
bott Laboratories, Abbot Park, Ill).
The distribution ofHp phenotypes in AAA patients was
compared with 1043 healthy Polish men (aged 19 to 48
years) from northwestern Poland (Table I) who underwent
Hp phenotyping as part of a paternity test in the Depart-
ment of Forensic Medicine at the same time as the AAA
patients were having their follow-up. Their health status
was assessed on the basis of interview and available medical
documentation. No aneurysms or any other comorbidities
were found in this group except 26 with diabetes mellitus.
Statistical analysis. The studied quantitative parame-
ters were compared among the Hp phenotype groups by
Kruskal-Wallis and Mann-Whitney tests. Qualitative pa-
rameters were analyzed with 2. The Spearman rank corre-
lation coefficient (r) was used to measure the strength of
correlations. A general linear model was used for multivar-
iate analysis with logarithmic transformation of variables
Table I. Distribution of haptoglobin (Hp) phenotypes in
patients with abdominal aortic aneurysm (AAA) and in
healthy controlsa
Hp phenotype Controls AAA group
No. (%) No. (%)
1-1 136 (13) 13 (16)
2-1 448 (43) 41 (49)
2-2 459 (44) 29 (35)
aThe distributions are not significantly different (P  .27, 2 test).with log-normal distribution for AAA diameter and growth
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P  .05 was considered statistically significant.
RESULTS
The distribution of Hp phenotypes in patients with
AAA was similar to the control group (Table I). The
characteristics of the AAA patients are reported in Table II.
The Hp phenotype groups were not significantly different
in age, gender, and pharmacologic treatment (P  .05 for
all comparisons, data not shown). The only comorbidity
significantly associated with the Hp phenotype was coro-
nary artery disease, present in 1Hp 1-1 patient (8%), 16Hp
2-1 patients (39%), and 20 Hp 2-2 patients (69%; P 
.0007, 2). At the last scan the AAA diameter was 30 to 49
mm in 21 patients (25%), 50 to 54 mm in 33 (40%), and
55 mm in 29 (35%).
The comparison of AAA diameter, growth rate, serum
elastase activity, and inflammation markers among the Hp
phenotypes is reported in Table III. Univariate analysis
showed that the Hp 2-1 phenotype was associated with a
lower initial AAA diameter, a higher increase of diameter
between the initial and final study, a higher AAA growth
rate (Fig), and shorter time of observation until the last
follow-up visit compared with the Hp 1-1 and Hp 2-2
phenotypes. Hp 2-1 was also associated with higher serum
elastase activity and CRP concentration than both homozy-
gous phenotypes. There were no significant differences in
final AAA diameter and neutrophil count. No differences
were found between Hp 1-1 and Hp 2-2 patients.
Table IV presents correlations of studied blood param-
eters with AAA growth rate and initial diameter. The AAA
growth rate correlated positively with serum elastase activ-
ity and CRP concentration in the entire group. A positive
correlation with elastase was also present within the Hp 2-1
Table II. Characteristics of 83 patients with abdominal
aortic aneurysm (AAA)a
Variable Mean  SD Median (IQR)
Age at initial examination, y 66.9  7.7 68 (11)
Initial AAA diameter, mm 40.8  8.7 39 (11)
Final AAA diameter, mm 52.2  8.7 52 (8)
Follow-up, mon 54.7  15.1 52 (28)
No. (%) —
Male gender 73 (88) —
Hypertension 42 (51) —
Coronary artery disease 37 (31) —
COPD 11 (13) —
Hernia repair 15 (18) —
Peripheral vascular disease 17 (21) —
Cerebrovascular disease 10 (12) —
Diabetes 7 (8) —
Active smokers 73 (88) —
Statins 74 (89) —
-blockers 31 (37) —
Antiplatelet drugs 83 (100) —
COPD, Chronic obstructive pulmonary disease; IQR, interquartile range.
aComorbidities and drugs taken at the initial examination are presented.subgroup. The growth rate correlated positively with theneutrophil count in Hp 2-1 patients. No correlations were
significant in Hp 1-1 and Hp 2-2 groups.
The initial AAA diameter correlated negatively with
serum elastase activity, but this association was significant
only in the entire AAA group. No significant associations
between AAA growth rate or inflammation markers and
age, gender, smoking, comorbidities, and pharmacologic
treatment were found (data not shown).
Multivariate analysis adjusted for age, gender, and vari-
ables significantly associated with Hp phenotype or growth
rate (AAA initial diameter, elastase activity, CRP, and pres-
ence of coronary artery disease) showed that the Hp 2-1
phenotype was the only independent predictor of a higher
AAA growth rate (significantly positive  coefficient) com-
pared with Hp 1-1 and 2-2 phenotypes (Table V). Another
multivariate analysis adjusted for age, gender, elastase ac-
tivity, CRP, and presence of coronary artery disease (Table
VI) showed that the Hp 2-1 phenotype was the only
independent predictor of a lower initial AAA diameter
(significantly negative  coefficient) compared with the Hp
2-2 phenotype; however, no association was significant in
the model when Hp 2-1 was compared with Hp 1-1. This
was probably due to a low number of Hp 1-1 patients. No
significant predictors of AAA growth rate or initial diameter
were found in multivariate models comparing Hp 1-1 and
Hp 2-2 phenotypes (data not shown).
DISCUSSION
AAA has a prevalence of 1.3% to 8.9% in men and 1.0%
to 2.2% in women aged 55 years and is a life-threatening
disease characterized by the progressive aortic dilation and
rupture. The rupture of a large AAA has a mortality rate of
up to 90%. Elective surgical or endovascular repair is rec-
ommended for large aneurysms, whereas small aneurysms
are managed by careful monitoring and patience. AAA
diameter and growth rate are the most important determi-
nants of the risk of rupture and the need for elective repair.
Therefore, systemic biomarkers associated with faster aneu-
rysm growth would be useful in clinical practice.
To the best of our knowledge, this is the first prospec-
tive study to analyze the association of AAA growth rate
with Hp phenotype. We showed that the Hp 2-1 pheno-
type is associated with the highest mean growth rate of
AAA. The association also remains significant after adjust-
ment for other variables correlating with the Hp phenotype
or growth rate. Moreover, the Hp 2-1 phenotype was
associated with the highest absolute AAA diameter increase
in the shortest period, proving that the association with the
highest growth rate is not solely dependent on the shortest
follow-up time. We therefore postulate that the Hp 2-1
phenotype is a strong independent risk factor of faster AAA
growth.
An increased frequency of the Hp 2-1 phenotype was
previously reported among AAA patients,8 but we did not
confirm this finding in our study patients. However, our
study confirmed the Hp 2 allele is associated with coronary
artery disease.5 Different values of mean annual rate of AAA
expansion have been reported, including 1.3,9 1.6,10 2.6,11
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Hp phenotype.
It is difficult to explain why the Hp 2-1 heterozygous
phenotype was different from both homozygous pheno-
types, and no differences were found between Hp 1-1 and
Hp 2-2 homozygotes. However, such mode of association
was previously reported in relation to other diseases. In
Crohn’s disease, patients with Hp 2-1 had a higher risk of
the inflammatory form compared with the other two ho-
mozygous phenotypes.14 A significant number of individ-
uals with Parkinson’s disease were carrying the Hp 2-1
phenotype,15 as were patients with a family history of
Table III. Comparison of abdominal aortic aneurysm (AA
markers among patients with various haptoglobin (Hp) ph
Parameters
Hp phenotype, med
1-1 2-1
Age at initial examination, y 68 (10) 68 (14)
AAA diameter, mm
Initial 43 (15) 38 (6)
Final 56 (10) 52 (7)
Increaseb 8 (5) 15 (9)
Follow-up, mon 66 (26) 45 (13)
Growth rate, mm/y 1.45 (0.68) 3.69 (2.4
Elastase activity, AUc 0.071 (0.040) 0.119 (0.0
CRP, mg/L 2.8 (4.1) 7.2 (7.1
Neutrophil count, G/L 5.5 (2.0) 5.7 (2.5
CRP, C-reactive protein; IQR, interquartile range.
aMann-Whitney test.
bDifference between final and initial AAA diameter.
cArbitrary units based on absorbance change.
Fig. Abdominal aortic aneurysm (AAA) growth rate i
types.ovarian carcinoma.4 It could be speculated that Hp 2-1phenotype might cumulate harmful features associated
with alleleHp 1 (stimulation of the elastin hydrolysis)6 and
allele Hp 2 (increased risk of atherosclerosis)5 to yield a
combination that is particularly efficient in promoting AAA
growth, but much more evidence is needed to support this
hypothesis.
Aneurysmal dilatation was linked with a significant in-
crease in aortic stiffness or inelasticity and with decreased
medial elastin content.16 Neutrophil elastase is a proteinase in
granulocytes that is important in the pathogenesis of inflam-
matory disorders because it causes medial degeneration.17
The neutrophil count and elastase contribute to the progres-
parameters, serum elastase activity, and inflammation
ypes
IQR) P valuea
2-2 2-1 vs 1-1 2-1 vs 2-2 2-2 vs 1-1
69 (11) .89 .77 .91
44 (12) .023 .0081 .52
51 (15) .38 .79 .27
8 (4) .0074 .00007 .77
62 (12) .0028 .00001 .81
1.24 (0.79) .00004 .00001 .14
0.064 (0.041) .0006 .00001 .65
3.4 (3.1) .044 .0058 .79
5.4 (1.8) .55 .95 .57
wn in patients with various haptoglobin (Hp) pheno-A)
enot
ian (
0)
84)
)
)s shosion of vascular disease.18 Moreover, elastin-derived peptides
lues o
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ing neutrophils.19 Circulating neutrophils and neutrophil-
associated proteinases are an important initial component of
AAA formation.20,21 In addition, the serum elastase activity
is associated with arterial stiffness and may be involved in
the process of aortic elasticity loss.22
The elasticity of the large arteries was significantly
lower in diabetic patients with Hp 2-1 and Hp 2-2 pheno-
type compared with Hp 1-1.23 The highest elastase activity
in our AAA patients was seen in the Hp 2-1 group, and the
AAA expansion rate significantly positively correlated with
serum elastase activity in the entire group and within those
with the Hp 2-1 phenotype. Some have suggested that
neutrophil elastase is a better and more accurate marker of
inflammation than CRP.24 This is consistent with our
results: a much stronger association with AAA growth rate
was found for elastase than for CRP.
Increased serum hsCRP levels have been reported dur-
ing the formation of AAA.25 Serum CRP concentrations
were threefold higher in patients with increased arterial
stiffness than in healthy controls.26 It is therefore probable
Table IV. Correlations of studied blood parameters with
diameter in all AAA patients and in subgroups with variou
Parameter
AAA group (n  83) Hp 1-1
r P value r
Correlations wi
Elastase activity 0.42 .00009 0.24
CRP level 0.32 .0031 0.14
Neutrophil count 0.17 .12 0.04
Correlations with
Elastase activity 0.29 .0068 0.50
CRP level 0.05 .63 0.11
Neutrophil count 0.01 .92 0.07
CRP, C-reactive protein.
aValues of Spearman rank correlation coefficients (r) with corresponding va
Table V. Multivariate analysis of predictors of abdominal
aortic aneurysm (AAA) growth ratea
Parameter
Hp 2-1 vs Hp 1-1 Hp 2-1 vs Hp 2-2
-
Coefficient P value
-
Coefficient P value
Age –0.06 .60 0.07 .48
Male gender –0.03 .81 0.09 .37
Coronary artery disease –0.10 .40 –0.11 .28
AAA initial diameterb –0.04 .74 0.01 .89
Serum elastase activityb 0.28 .055 0.09 .44
Serum CRPb 0.19 .14 0.13 .20
Hp 2-1 phenotype 0.34 .021 0.48 .00026
CRP, C-reactive protein; Hp, haptoglobin.
aA general linear model was used with the logarithm of growth rate as the
dependent variable and seven independent variables. Models for comparison
of Hp 2-1 with each of the homozygous phenotypes are presented.
bThis variable was transformed logarithmically before analysis.that the increased serum hsCRP levels are related to theenhanced elastin degradation within aneurysm wall. Nor-
man et al10 demonstrated that the CRP levels do not appear
to be associated with rapid expansion. In our study, CRP
correlated with AAA growth rate in the entire group, but
the association was not significant in the multivariate
model.
Although the Hp 2-1 group had the highest elastase
activity, the neutrophil count was similar in all the Hp
groups. This is consistent with the observation that neutro-
phil elastase did not correlate with the leucocyte count in
vascular disease.18 Biologically active peptides generated
from CRP by neutrophil elastase promote neutrophil apo-
ptosis,27 and this phenomenon might explain the lack of
association betweenHp and neutrophil count. The neutro-
phil count in our patients correlated positively with aneu-
rysm growth rate only in the Hp 2-1 group.
Our study has several limitations that should be ac-
counted for when interpreting the results. Patients in the
study group had a wide range of initial AAA diameters and
follow-up times. We could not establish the outcome of
patients after the last examination.
The AAA diameter was measured with ultrasound im-
aging and not computed tomography, because computed
minal aortic aneurysm (AAA) growth rate and initial
toglobin (Hp) phenotypesa
13) Hp 2-1 (n  41) Hp 2-2 (n  29)
value r P value r P value
A growth rate
.43 0.45 .0033 0.23 .23
.64 0.25 .11 0.03 .86
.90 0.33 .035 0.10 .62
al AAA diameter
.079 0.08 .64 0.19 .32
.72 0.15 .34 0.09 .64
.82 0.06 .69 0.12 .53
f P are presented.
Table VI. Multivariate analysis of predictors of abdominal
aortic aneurysm initial diametera
Parameter
Hp 2-1 vs Hp 1-1 Hp 2-1 vs Hp 2-2
-
Coefficient P value
-
Coefficient P value
Age 0.19 .15 0.14 .22
Male gender 0.20 .12 0.09 .47
Coronary artery disease –0.08 .55 –0.03 .80
Serum elastase activityb –0.28 .076 –0.13 .37
Serum CRPb 0.05 .72 0.09 .48
Hp 2-1 phenotype –0.23 .13 –0.31 .035
CRP, C-reactive protein; Hp, haptoglobin.
aA general linear model was used with the logarithm of initial diameter as the
dependent variable and six independent variables. Models for comparison of
Hp 2-1 with each of the homozygous phenotypes are presented.
bVariable was transformed logarithmically before analysis.abdo
s hap
(n 
P
th AA
inititomography is not convenient for repeated measurements.
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sured only at the initial examination and were not moni-
tored during follow-up. No serum lipids were assessed.
Further studies with a larger and a more homogenous
group of AAA patients are needed to confirm our results.
CONCLUSIONS
We suggest that the Hp 2-1 phenotype is a strong
independent predictor of rapid aneurysm growth. This may
have implications for the frequency of follow-up and timing
of repair of AAA in patients with Hp 2-1 phenotype. The
pathomechanisms of the association of haptoglobin, elas-
tase, and inflammation with AAA growth need further
research.
We thank Gary Stewart, a native-English-speaking
translator, for his assistance in the preparation of the manu-
script.
AUTHOR CONTRIBUTIONS
Conception and design: IW
Analysis and interpretation: IW, KS, JP
Data collection: IB, JP
Writing the article: IW, KS
Critical revision of the article: KS
Final approval of the article: PG
Statistical analysis: KS
Obtained funding: IW
Overall responsibility: IW
REFERENCES
1. Sandford RM, Bown MJ, London NJ, Sayers RD. The genetic basis of
abdominal aortic aneurysms: a review. Eur J Vasc Endovasc Surg
2007;33:381-90.
2. Wanhainen A, Bergqvist D, Boman K, Nilsson TK, Rutegard J, Bjorck
M. Risk factors associated with abdominal aortic aneurysm: a population-
based study with historical and current data. J Vasc Surg 2005;41:
390-6.
3. Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and
disorders. Am J Clin Pathol 2004;121(suppl):S97-104.
4. Langlois MR, Delanghe JR. Biological and clinical significance of
haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
5. Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, Asaf R,
et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation,
and macrophage accumulation in the atherosclerotic plaque. Arterio-
scler Thromb Vasc Biol 2007;27:134-40.
6. Powell JT, Bashir A, Dawson S, Vine N, Henney AM, Humphries SE,
et al. Genetic variation on chromosome 16 is associated with abdominal
aortic aneurysm. Clin Sci 1990;78:13-6.
7. Wiernicki I, Gutowski P, Ciechanowski K, Millo B, Wieczorek P,
Cnotliwy M, et al. Abdominal aortic aneurysm: association between
haptoglobin phenotypes, elastase activity, and neutrophil count in the
peripheral blood. Vasc Surg 2001;35:345-50.
8. Norrgård O, Fröhlander N, Beckman G, Angqvist KA. Association
between haptoglobin groups and aortic abdominal aneurysms. Hum
Hered 1984;34:166-9.9. MacSweeney ST, Ellis M, Worrell PC, Greenhalgh RM, Powell JT.
Smoking and growth rate of small abdominal aortic aneurysms. Lancet
1994;344:651-2.
10. Norman P, Spencer CA, Lawrence-BrownMM, Jamrozik K. C-reactive
protein levels and the expansion of screen-detected abdominal aortic
aneurysms in men. Circulation 2004;110:862-6.
11. Wolf YG, Thomas WS, Brennan FJ, Goff WG, Sise MJ, Bernstein EF.
Computed tomography scanning findings associated with rapid expan-
sion of abdominal aortic aneurysms. J Vasc Surg 1994;20:529-35.
12. Stonebridge PA, Draper T, Kelman J, Howlett J, Allan PL, Prescott R,
et al. Growth rate of infrarenal aortic aneurysms. Eur J Vasc Endovasc
Surg 1996;11:70-3.
13. Vega de Céniga M, Gómez R, Estallo L, de la Fuente N, Viviens B,
Barba A. Analysis of expansion patterns in 4-4.9 cm abdominal aortic
aneurysms. Ann Vasc Surg 2008;22:37-44.
14. PappM. Possible pathogenic role of vascular, immunologic and genetic
factors in certain gastroenterologic disorders [abstract]. Orv Hetil
2008;149:2269-76.
15. Costa-Mallen P, Checkoway H, Zabeti A, Edenfield MJ, Swanson PD,
Longstreth WT, et al. The functional polymorphism of the hemoglobin-
binding protein haptoglobin influences susceptibility to idiopathic Par-
kinson’s disease. Am J Med Genet B Neuropsychiatr Genet1 2008;
147B:216-22.
16. MacSweeney ST, Young G, Greenhalgh RM, Powell JT. Mechanical
properties of the aneurysmal aorta. Br J Surg 1992;79:1281-4.
17. Rizas KD, Ippagunta N, Tilson MD 3rd. Immune cells and molecular
mediators in the pathogenesis of the abdominal aortic aneurysm. Car-
diol Rev 2009;17:201-10.
18. Jackson MH, Collier A, Nicoll JJ, Muir AL, Dawes J, Clarke BF, et al.
Neutrophil count and activation in vascular disease. Scott Med J 1992;
37:41-3.
19. Cohen JR, Parikh S, Grella L, Sarfati I, Corbie G, Danna D, et al. Role
of the neutrophil in abdominal aortic aneurysm development. Cardio-
vasc Surg 1993;1:373-6.
20. Houard X, Touat Z, Ollivier V, Louedec L, PhilippeM, SebbagU, et al.
Mediators of neutrophil recruitment in human abdominal aortic aneu-
rysms. Cardiovasc Res 2009;82:532-41.
21. Pagano MB, Zhou HF, Ennis TL, Wu X, Lambris JD, Atkinson JP,
et al. Complement-dependent neutrophil recruitment is critical for the
development of elastase-induced abdominal aortic aneurysm. Circula-
tion 2009;119:1805-13.
22. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja
K, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum
elastase activity are associated with systolic hypertension and arterial
stiffness. Arterioscler Thromb Vasc Biol 2005;25:372.
23. Shor M, Boaz M, Gavish D, Wainshtein J, Matas Z, Shargorodsky M.
Relation of haptoglobin phenotype to early vascular changes in patients
with diabetes mellitus. Am J Cardiol 2007;100:1767-70.
24. Schietroma M, Carlei F, Cappelli S, Pescosolido A, Lygidakis NJ,
Amicucci G. Effects of cholecystectomy (laparoscopic versus open) on
PMN-elastase. Hepatogastroenterology 2007;54:342-5.
25. Huang G, Wang A, Li X, Long M, Du Z, Hu C, et al. Change in
high-sensitive C-reactive protein during abdominal aortic aneurysm
formation. J Hypertens 2009;27:1829-37.
26. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D,
et al. Increased arterial stiffness in patients with chronic obstructive
pulmonary disease: a mechanism for increased cardiovascular risk. Tho-
rax 2008;63:306-11.
27. Kakuta Y, Aoshiba K, Nagai A. C-reactive protein products generated
by neutrophil elastase promote neutrophil apoptosis. Arch Med Res
2006;37:456-60.Submitted Nov 20, 2009; accepted Mar 7, 2010.
